364 related articles for article (PubMed ID: 16904048)
21. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
Loveman E; Green C; Kirby J; Takeda A; Picot J; Payne E; Clegg A
Health Technol Assess; 2006 Jan; 10(1):iii-iv, ix-xi, 1-160. PubMed ID: 16409879
[TBL] [Abstract][Full Text] [Related]
22. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators.
Connors AF; Speroff T; Dawson NV; Thomas C; Harrell FE; Wagner D; Desbiens N; Goldman L; Wu AW; Califf RM; Fulkerson WJ; Vidaillet H; Broste S; Bellamy P; Lynn J; Knaus WA
JAMA; 1996 Sep; 276(11):889-97. PubMed ID: 8782638
[TBL] [Abstract][Full Text] [Related]
23. Clinical and economic effects of pulmonary artery catheterization in nonemergent coronary artery bypass graft surgery.
Ramsey SD; Saint S; Sullivan SD; Dey L; Kelley K; Bowdle A
J Cardiothorac Vasc Anesth; 2000 Apr; 14(2):113-8. PubMed ID: 10794325
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the ventricular assist device programme in the UK.
Sharples L; Buxton M; Caine N; Cafferty F; Demiris N; Dyer M; Freeman C
Health Technol Assess; 2006 Nov; 10(48):1-119, iii-iv. PubMed ID: 17134596
[TBL] [Abstract][Full Text] [Related]
25. Is it 'worthwhile' to continue treating patients with a prolonged stay (>14 days) in the ICU? An economic evaluation.
Heyland DK; Konopad E; Noseworthy TW; Johnston R; Gafni A
Chest; 1998 Jul; 114(1):192-8. PubMed ID: 9674469
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.
Sharples L; Hughes V; Crean A; Dyer M; Buxton M; Goldsmith K; Stone D
Health Technol Assess; 2007 Dec; 11(49):iii-iv, ix-115. PubMed ID: 18021576
[TBL] [Abstract][Full Text] [Related]
27. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of pulmonary artery catheter use in multicenter ICUs in Japan and the association with mortality: a multicenter cohort study using the Japanese Intensive care PAtient Database.
Fukano K; Iizuka Y; Nishiyama S; Yoshinaga K; Uchino S; Sasabuchi Y; Sanui M
Crit Care; 2023 Oct; 27(1):412. PubMed ID: 37898794
[TBL] [Abstract][Full Text] [Related]
29. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
30. Effect of a Quality Improvement Intervention With Daily Round Checklists, Goal Setting, and Clinician Prompting on Mortality of Critically Ill Patients: A Randomized Clinical Trial.
; Cavalcanti AB; Bozza FA; Machado FR; Salluh JI; Campagnucci VP; Vendramim P; Guimaraes HP; Normilio-Silva K; Damiani LP; Romano E; Carrara F; Lubarino Diniz de Souza J; Silva AR; Ramos GV; Teixeira C; Brandão da Silva N; Chang CC; Angus DC; Berwanger O
JAMA; 2016 Apr; 315(14):1480-90. PubMed ID: 27115264
[TBL] [Abstract][Full Text] [Related]
31. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
32. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
[TBL] [Abstract][Full Text] [Related]
33. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
[TBL] [Abstract][Full Text] [Related]
34. Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial.
Rivero-Arias O; Campbell H; Gray A; Fairbank J; Frost H; Wilson-MacDonald J
BMJ; 2005 May; 330(7502):1239. PubMed ID: 15911536
[TBL] [Abstract][Full Text] [Related]
35. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.
Binanay C; Califf RM; Hasselblad V; O'Connor CM; Shah MR; Sopko G; Stevenson LW; Francis GS; Leier CV; Miller LW;
JAMA; 2005 Oct; 294(13):1625-33. PubMed ID: 16204662
[TBL] [Abstract][Full Text] [Related]
36. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
37. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial.
Richard C; Warszawski J; Anguel N; Deye N; Combes A; Barnoud D; Boulain T; Lefort Y; Fartoukh M; Baud F; Boyer A; Brochard L; Teboul JL;
JAMA; 2003 Nov; 290(20):2713-20. PubMed ID: 14645314
[TBL] [Abstract][Full Text] [Related]
38. Home treatment for mental health problems: a systematic review.
Burns T; Knapp M; Catty J; Healey A; Henderson J; Watt H; Wright C
Health Technol Assess; 2001; 5(15):1-139. PubMed ID: 11532236
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.
Harrison D; Muskett H; Harvey S; Grieve R; Shahin J; Patel K; Sadique Z; Allen E; Dybowski R; Jit M; Edgeworth J; Kibbler C; Barnes R; Soni N; Rowan K
Health Technol Assess; 2013 Feb; 17(3):1-156. PubMed ID: 23369845
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
